title: Quality of life assessment in the TAX 326 study.
authors.forename: Fergus R
authors.initials: FR
authors.lastname: Macbeth
authors.forename: Jason F
authors.initials: JF
authors.lastname: Lester
mesh_terms: D000203:Activities of Daily Living; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001835:Body Weight / Q000187:drug effects; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage; D000077143:Docetaxel; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000517:prevention & control; D010349:Patient Compliance; D010984:Platinum / Q000008:administration & dosage; D011597:Psychomotor Performance / Q000187:drug effects; D011788:Quality of Life; D018434:Sickness Impact Profile; D043823:Taxoids / Q000008:administration & dosage; D016896:Treatment Outcome; D014747:Vinblastine / Q000008:administration & dosage / Q000031:analogs & derivatives; D000077235:Vinorelbine
chemical_list: D043823:Taxoids; D000077143:Docetaxel; D010984:Platinum; D014747:Vinblastine; D002945:Cisplatin; D000077235:Vinorelbine